Novartis Says Kidney Drug Phase 3 Trial Reaches Positive Interim Result
By Adria Calatayud Novartis said an interim analysis from a phase 3 trial to evaluate its investigational iptacopan drug in patients with kidney disease nephropathy achieved positive results,…
Read more Novartis Says Kidney Drug Phase 3 Trial Reaches Positive Interim Result